Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -37.39% is 45% above its 2-year average of -68.59%, near the high end of its 2-year range (-108.27%–-28.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.59% below its 12-month average of -36.81%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -37.39%.
RETURN ON INVESTED CAPITAL (ROIC)
-37.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.59%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 733 covered companies
CURRENT VS SECTOR MEDIAN
-11.63%
vs the sector median at left
Jade Biosciences, Inc.
Market Cap
$821.00M
Return on Invested Capital (ROIC)
-37.39%
TTM Avg
-36.81%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$808.58M
Return on Invested Capital (ROIC)
-7.99%
TTM Avg
-8.85%
3Y Avg
-21.37%
5Y Avg
-42.56%
Market Cap
$833.97M
Return on Invested Capital (ROIC)
-23.80%
TTM Avg
-58.06%
3Y Avg
-39.20%
5Y Avg
-32.57%
Market Cap
$806.17M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
Market Cap
$837.51M
Return on Invested Capital (ROIC)
-26.54%
TTM Avg
-38.64%
3Y Avg
-38.64%
5Y Avg
-38.64%
Market Cap
$840.86M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
Market Cap
$844.79M
Return on Invested Capital (ROIC)
-28.69%
TTM Avg
-21.44%
3Y Avg
-33.52%
5Y Avg
-49.04%
Market Cap
$797.32M
Return on Invested Capital (ROIC)
-0.26%
TTM Avg
4.90%
3Y Avg
-0.53%
5Y Avg
1.15%
Market Cap
$843.04M
Return on Invested Capital (ROIC)
-94.76%
TTM Avg
-114.06%
3Y Avg
-144.57%
5Y Avg
-144.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $821.00M | -37.39% | -36.81% | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $808.58M | -7.99% | -8.85% | -21.37% | -42.56% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $833.97M | -23.80% | -58.06% | -39.20% | -32.57% |
| InMode Ltd. (INMD)vs › | $806.17M | 9.20% | 13.08% | 19.17% | 23.78% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $837.51M | -26.54% | -38.64% | -38.64% | -38.64% |
| Beta Bionics, Inc. (BBNX)vs › | $840.86M | -31.17% | -29.64% | -85.48% | -85.48% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $844.79M | -28.69% | -21.44% | -33.52% | -49.04% |
| AdaptHealth Corp. (AHCO)vs › | $797.32M | -0.26% | 4.90% | -0.53% | 1.15% |
| Alumis Inc. (ALMS)vs › | $843.04M | -94.76% | -114.06% | -144.57% | -144.57% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $793.24M | -9.77% | 8.57% | -11.39% | -51.99% |
ROIC
-37.4%
ROE
-34.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -37.39% |
| 2026-03-31 | -44.96% |
| 2025-12-31 | -28.07% |
| 2024-12-31 | -93.80% |
| 2024-09-30 | -108.27% |
| 2024-06-30 | -99.02% |
